Composer is the no-code algorithmic strategy builder with auto-execution through an integrated brokerage, $20-99/month. invest-like is the seven-framework value-investing verdict tool at $13/month annual. Honest head-to-head on what each tool actually does, who wins where, and when you should use both.
What is the best PE ratio for value investing? There is no universal answer, here's the worked-example proof
Every beginner asks what PE ratio counts as cheap. The honest answer is that there is no universal number. A PE of 15 in software is a screaming bargain. A PE of 15 in a utility is fairly priced. A PE of 15 in a coal miner is expensive. We walk through three sectors with worked examples.
Value investing in tech, is it an oxymoron? 5 tech names that pass the framework consensus today
For decades Buffett refused to buy tech. Then he bought Apple in 2016 and made over 100 billion in gains. Munger bought BABA. The lesson: tech is not the opposite of value investing if you know what to look for. Five tech names that pass the invest-like 7-framework screen today.
Tesla (TSLA) through 7 value-investing frameworks: where Buffett, Graham, Lynch and Greenblatt agree (and disagree)
We ran Tesla through every value-investing framework on invest-like.com. Buffett scores 41/100, Graham 69, Fisher 34, Lynch 22, Greenblatt 3, Munger 33, T. Smith 39. Six of seven frameworks reject TSLA outright. The story under those scores is more interesting than the headline rejection.
Composer.trade and invest-like both show up in lists of "AI-powered investing tools", but they are doing completely different jobs once you look past the marketing. Composer is a no-code algorithmic strategy builder where you compose rule-based trading symphonies and Composer auto-executes them through its integrated brokerage. invest-like is a stock-by-stock research tool where seven legendary investor frameworks score each name and the user reads the verdicts to make their own buy decision.
They are closer to complementary than competing. Composer is "build the rules and let it run". invest-like is "evaluate each individual stock against published frameworks". Both can live in the same toolkit without overlap.
Disclosure up front: I built invest-like, so I have a structural conflict of interest. Composer is genuinely better than invest-like on the dimensions where it is built to win, and I will say so explicitly. The goal of this post is to help you pick the right tool for your specific workflow.
| Feature | invest-like | Composer.trade |
|---|---|---|
| Starting price | Free tier + $13/month annual (12 EUR) | $20/month (Starter), up to $99/month (Pro) |
| Higher tier | $15/month or $299 lifetime | $99/month Pro tier |
| What it does | Stock research + framework verdicts | No-code algorithmic strategy automation |
| Coverage universe | ~12,500 tickers | Broad US equities and ETFs |
| AI verdicts on stocks with reasoning | Yes (Buffett Brain, 5-pillar) | No (strategy-level, not stock-level) |
| Multi-investor framework consensus | Yes (7 frameworks: Buffett, Graham, Lynch, Greenblatt, Munger, Fisher, Smith) | No |
| Multi-investor debate UI | Yes (Boardroom: 4 investor AIs + skeptic) | No |
| RAG over Berkshire shareholder letters | Yes (Ask Buffett, 1977-2025) | No |
| Published 5-year backtest | Yes (track-record page) | Yes (per-symphony backtests, but user-built) |
| No-code strategy builder | No | Yes (signature feature) |
| Auto-execution through integrated broker | No (analysis only) | Yes (signature feature) |
| Conditional rule logic and rebalancing | No | Yes (deep) |
| Halal screening (AAOIFI Standard 21) | Yes | No |
| Multi-language UI | Yes (EN, DE, FR, ES, PT) | English-only |
| Free tier | Yes (3 AI verdicts/week + all rankings) | Limited free, mostly paid |
| Team age + size | Solo founder, 2026 launch | Larger team, founded 2020 |
The short read: Composer wins on systematic strategy automation, conditional rule logic, and execution integration. invest-like wins on stock-by-stock fundamental research, multi-investor framework consensus, Berkshire-letter RAG, and published cohort backtest. They are answering different questions. Most serious retail investors who use both have one for the rules layer and one for the picks layer.
Composer has been around since 2020 and the team has poured real engineering into the strategy-composition surface. A few places they are clearly ahead.
Composer's signature feature is the visual symphony composer. You drag and drop blocks like "if SPY 200-day moving average is above current price, allocate 60 percent to QQQ, else allocate to cash", chain conditions, set rebalancing rules, and Composer compiles that into an actual executable strategy. No Python required, no API keys, no quant background needed.
This is genuinely a hard problem solved well. The UX is approachable for retail users while the underlying logic is rich enough to express real strategies.
invest-like has nothing like this. We score individual stocks, we do not build systematic strategies on top of them. If your workflow is "I want to run a rule-based asset-rotation strategy and have it actually execute", Composer is the tool and invest-like is not.
Once you build a symphony on Composer, you can fund it and Composer auto-executes the trades through its integrated brokerage. Rebalancing, dollar-cost averaging, conditional rotations, all handled automatically.
invest-like is analysis-only. You take the verdict, switch to your own broker (Fidelity, Schwab, Robinhood, whatever), and place the trade there. No execution layer.
If the "research to execution" handoff is friction you want eliminated, Composer is structurally built for that and invest-like is not.
Composer lets you backtest any symphony you build against historical data. Adjust the rules, see how the strategy would have performed over 5 or 10 years, iterate. This is a real quant-style workflow made accessible to non-coders.
invest-like publishes one backtest (the 7-of-7 framework consensus cohort). It is not a platform where you build your own strategies and backtest them yourself. The backtest at /track-record/ is a single methodology, not a backtesting sandbox.
Composer ships a library of user-published symphonies you can browse, fork, and run. If you want to start from a community strategy and tweak it, the library is a real asset.
invest-like is a research tool, not a strategy marketplace. You read the framework verdicts, you make your own decisions.
Composer is genuinely strong for ETF and asset-rotation strategies (think "60/40 with momentum overlay" or "tactical sector rotation based on relative strength"). The symphony composer was designed with these patterns in mind.
invest-like is stocks-only. We do not score ETFs, and the seven value-investing frameworks (Buffett, Graham, Lynch, etc.) do not really apply to a basket of stocks.
invest-like is not trying to build executable strategies. It is trying to be the verdict layer that helps you decide which individual stocks to own. Here is where that approach wins.
invest-like's Buffett Brain produces a structured 5-pillar verdict for any stock: moat, durability of competitive advantage, management quality, financial strength, and valuation. Each pillar gets its own paragraph with the specific data point that triggered the scoring decision, so you can verify or disagree with each line.
Composer does not produce stock-level fundamental verdicts. Its analytics are strategy-level (how does this symphony perform), not stock-level (should I own this specific company at this price). If you want "is Apple a Buffett-quality business at the current price and why", invest-like answers that and Composer does not.
invest-like runs every stock against the published rules of seven legendary investors separately: Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, and Terry Smith. Each framework returns a pass/partial/fail verdict with the underlying number. The composite "7-of-7 consensus" tier (currently 47 stocks) is the highest-conviction signal on the platform.
Composer's symphonies can encode rules (RSI thresholds, moving-average crossovers, momentum factors), but they do not encode the qualitative fundamental frameworks of Buffett, Graham, or Lynch in the same way. Those frameworks are not really expressible as if/then trading rules. invest-like ships them as verdicts, Composer does not.
invest-like's Boardroom simulates a live debate between four investor AIs (Buffett, Graham, Lynch, Greenblatt) plus a dedicated skeptic role, each arguing from their actual framework rules with citations. No competitor in the retail category ships this format, including Composer.
invest-like indexes every Berkshire Hathaway shareholder letter from 1977 to 2025, plus Charlie Munger's commentary. Ask Buffett a question about any stock and the answer cites the specific letter year and section. Real quotes from the actual source text, not training-data guesses. Composer has no equivalent.
invest-like publishes the open backtest at /track-record/. The 7-of-7 framework consensus cohort (47 stocks as of May 2026) returned a median +73.8 percentage points above the S&P 500 over a rolling 5-year window, with about 85 percent of the cohort beating the index. Server-locked entry timestamps, documented methodology.
This is different from Composer's backtesting sandbox. Composer lets you backtest your own custom strategies (which is more flexible). invest-like publishes one specific methodology's track record (which is more independently verifiable as a single claim).
invest-like applies the AAOIFI Standard 21 halal screen on every stock and layers it on top of the 7-framework consensus. If you are a Shariah-compliant investor wanting both the halal filter and the value-investing rigour, invest-like is currently one of the only retail tools that combines them. Composer does not ship a halal-eligibility filter on its instrument universe.
invest-like ships in English, German, French, Spanish, and Portuguese. Composer is English-only. If you read research in your native language matters, invest-like covers more ground.
invest-like is an analysis tool. We do not custody assets, we do not place trades, we do not earn execution revenue. The framework verdicts are independent of any trade. Composer is a broker-dealer with auto-execution, which creates a different (broader, more useful for some users, but more complex) regulatory and incentive surface.
If you specifically want the analysis layer to be structurally independent from execution, invest-like is cleaner. If you want the all-in-one platform, Composer is what you want.
You will probably get more out of Composer if:
You will probably get more out of invest-like if:
These two tools are genuinely complementary for a serious retail investor who does both systematic strategies and individual stock-picking:
Total cost: roughly $33 per month combined at entry tiers. Cheaper than a single Bloomberg seat by a factor of about 1,200, and you get coverage of two genuinely different workflows.
The honest test: pick the actual job you are trying to do. If your bottleneck is "I want a systematic strategy that rebalances based on rules", Composer is the answer and invest-like is the wrong tool. If your bottleneck is "I want to evaluate whether Apple is a Buffett-quality business at the current price", invest-like is the answer and Composer is the wrong tool.
Specifically:
If both feel useful for different reasons, that is the realistic answer for many serious investors. They are not substitutes.
Is Composer worth $20 to $99 per month? If your workflow is building and running systematic strategies, yes. The no-code symphony composer plus auto-execution is genuinely novel at retail pricing. If you only invest in individual stocks via your own broker and never plan to run a rule-based strategy, the value is much lower.
Is invest-like worth $13 per month? If your workflow involves applying value-investing frameworks (Buffett, Graham, Lynch, Greenblatt, Munger, Fisher, Smith) to individual stocks, yes. The free tier gives you three AI verdicts per week and all the ranking pages, so you can evaluate the methodology before paying anything.
Can Composer do fundamental stock analysis? Composer's strength is rule composition and execution, not fundamental analysis. You can encode some fundamental rules (P/E thresholds, dividend yield, etc.) into a symphony, but it does not produce a structured Buffett-style verdict on a single stock the way invest-like does.
Can invest-like execute trades? No. invest-like is purely an analysis tool. You read the framework verdicts, then switch to your own broker (Fidelity, Schwab, Robinhood, IBKR, etc.) to place the trade.
Are Composer's auto-executed strategies safe? Composer is a regulated broker-dealer in the US, so the execution infrastructure has the standard protections. The "safety" question is really about the strategies themselves. A backtested symphony can still lose money in live markets, especially in regimes that did not appear in the backtest data. Treat backtests as inputs, not guarantees.
Can I trust invest-like's verdicts? The methodology is documented at /methodology/buffett-fit/, and the 5-year backtest is at /track-record/. Trust the methodology, not the verdict in isolation. If the methodology makes sense to you and the backtest holds up, the verdicts are useful inputs into your own decision. They are not a recommendation.
Which one is more "AI"? Both market themselves as AI tools but the AI is doing different work. Composer uses some ML for strategy suggestions and natural-language symphony creation, but the core is rule-based. invest-like uses large language models to generate the structured per-pillar Buffett verdict and the Boardroom debate. Different shapes of AI for different jobs.
This is an opinionated comparison written by the founder of invest-like. Composer is a genuinely strong product in the systematic-strategy automation category and I have tried to be specific about where they win. If you think I have mischaracterised Composer anywhere, please email me at zaid@invest-like.com and I will update the post.
Composer is a product of Composer Technologies Inc., not affiliated with invest-like. Composer is a registered broker-dealer with its own regulatory disclosures around managed strategies and auto-execution. invest-like is an educational analysis tool, not a broker-dealer or investment adviser. Past framework verdicts and past backtest results do not guarantee future stock returns. Do your own research.
Author: Zaid Ghazal, founder of invest-like, indie SaaS, Kiel, Germany.